Accelerate NY Seed Fund Awards Bioharmony Therapeutics $100,000
-
Accelerate NY Seed Fund and Bioharmony Therapeutics announced today an investment by ANY in Bioharmony, a New York-based company developing first-in-class antimicrobials against multidrug resistant bacterial infections. These antimicrobials, called lysins, are enzymes that digest the cell wall of bacteria leading to rapid cell death. ANY invested $100,000 in the company’s seed round.